Virta wins head-to-head vendor competition against Weight Watchers and Noom
ROI claims are as plentiful as the number of point solutions in digital health, so Virta’s research team recently undertook a study to understand the financial impacts of our diabetes reversal treatment using a claims-based analysis.
By 100 days, patients on average lost 19 lbs and eliminated 67% of diabetes-specific medication prescriptions. By one year, 90% of patients continued with Virta, with continued medication reductions and cost savings.
The Virta Treatment delivers results that endure. Our patients experience clinically significant health improvements that last for two years—and counting.
US Foods, a leading food distributor with more than 25,000 employees, shares its 6-month outcomes, including how nearly half of its participants reversed their type 2 diabetes.
Nielsen, a data and measurement firm with over 4,400 employees, presents Virta's 1-year outcomes, including cutting insulin utilization by 50%.
Listen to three experts discuss the groundbreaking diabetes remission consensus statement released in August 2021.
Get information on COVID-19 and Diabetes from Virta's clinical leadership and industry thought leaders.
Tippecanoe County, located in the west-central portion of Indiana, covers nearly 1,200 employees and their dependents. Learn how Virta eliminated 70% of diabetes prescription drugs after just 6 months.
BBVA VP & Employee Benefits Consultant shares the details behind their game changing transition from diabetes management to reversal.
The Deputy Director of HR for the City of Fort Worth talks about his partnership with Virta and the resulting paradigm shift in his benefits strategy.
Nebraska Medicine's Employee Wellbeing and Safety Manager talks about caring for the caregivers and how she's used Virta to change hundreds of lives for the better.
